Prevacid

DRUG5 trials

Sponsors

AstraZeneca, Emory University, Vanderbilt University Medical Center, University of California, Davis, Procter and Gamble

Conditions

Gastroesophageal RefluxHealthyLaryngopharyngeal RefluxLarynx DiseaseStomach Ulcer

Phase 1

Twice Daily Prevacid for the Treatment of Laryngopharyngeal Reflux

CompletedNCT00864396

University of California, DavisLaryngopharyngeal Reflux

Start: 2005-07-31End: 2008-05-31Updated: 2017-03-27

Phase 4

Study of 24-hour Intragastric pH Profiles of Esomeprazole 40 mg and Lansoprazole 30 mg in Healthy Volunteer Subjects

CompletedNCT00230516

AstraZenecaHealthy

Start: 2005-09-30End: 2006-02-28Target: 100Updated: 2013-01-04

Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer

CompletedNCT00239551

Emory UniversityStomach Ulcer

Start: 2005-10-31End: 2007-12-31Updated: 2013-07-31

Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?

CompletedNCT00444145

Vanderbilt University Medical CenterGastroesophageal Reflux, Larynx Disease

Start: 2007-03-31End: 2009-12-31Updated: 2017-03-29

Comparison of Prilosec Over-the-counter (OTC)® Versus Prevacid® for Gastric Acid Suppression

CompletedNCT00903448

Procter and GambleHealthy

Start: 2009-04-30End: 2009-06-30Updated: 2010-12-31